DTU
DTU

Fasting Hyperglycaemia Study

Principal investigator:Rury Holman

Funder:MRC
Servier

The Fasting Hyperglycaemia Study (FHS) was a six-year, prospective, randomised, placebo-controlled study in subjects who had two consecutive fasting plasma glucose levels in the range 5.5 to 7.7 mmol/L and were thought to be at risk of developing diabetes. The primary aim of the trial was to determine whether deterioration in glycaemic tolerance towards diabetes can be delayed or prevented using an insulin secretagogue (sulphonylurea) or reinforced healthy living advice.

Results

The results of the FHS trial where presented at the EASD meeting in Jerusalem on 19 September 2000.

News

FHS results presented in Jerusalem

19-Sep-2000

The results of the FHS trial where presented at the EASD meeting in Jerusalem.

[Link]

FHS sulphonylurea paper published

01-Dec-1997
News Image

Randomised controlled trial of sulphonylurea therapy for subjects with increased fasting glucose levels
FHS group, Karunakaran S, Hammersley MS, Morris RJ, Turner RC, Holman RR
Metabolism 1997;46:56-60

[Link]

FHS healthy-living paper published

01-Dec-1997
News Image

Randomised controlled trial of enforced healthy-living advice in subjects with increased but not diabetic fasting glucose
Fasting hyperglycaemia Study Group, Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC
Metabolism 1997;46:50-55

[Link]


[News archive]